What type of study is this?

This is a Retrospective Cohort Study study.

September 10, 2025Frontiers in Cardiovascular MedicineOpen Access

Venous thromboembolism prophylaxis practices in hematology/oncology patients admitted to neurological intensive care units

View Full Paper

Ask AI

Bookmark

Authors

NANada Alsuhebany LALama Alfehaid DADanah Alodhaibi

Discussion

Member takes

Overview

Retrospective cohort analysis shows bleeding events in patients with solid tumors and hematologic malignancies, highlighting VTE prophylaxis strategies.

Key Points

The study found that 21% of patients with solid tumors experienced major bleeding events during hospitalization.
Among 168 screened patients, 43 were included, 38 of whom had solid tumors, indicating a significant focus on hematology and oncology.
A majority of patients, 81.3%, received chemical VTE prophylaxis, showcasing the importance of preventive measures in this population.
The findings emphasize the necessity for individualized care as 14% of patients experienced 30-day mortality despite the absence of thrombotic events.

Cite This Study

Alsuhebany et al. (2025) studied this question.

synapsesocial.com/papers/68c1a13a54b1d3bfb60dc92b https://doi.org/10.3389/fcvm.2025.1573080

View Full Paper

Ask AI

Bookmark

September 10, 2025Frontiers in Cardiovascular MedicineOpen Access

Venous thromboembolism prophylaxis practices in hematology/oncology patients admitted to neurological intensive care units

View Full Paper

Ask AI

Bookmark

Authors

NANada Alsuhebany LALama Alfehaid DADanah Alodhaibi

Discussion

Member takes

Overview

Retrospective cohort analysis shows bleeding events in patients with solid tumors and hematologic malignancies, highlighting VTE prophylaxis strategies.

Key Points

The study found that 21% of patients with solid tumors experienced major bleeding events during hospitalization.
Among 168 screened patients, 43 were included, 38 of whom had solid tumors, indicating a significant focus on hematology and oncology.
A majority of patients, 81.3%, received chemical VTE prophylaxis, showcasing the importance of preventive measures in this population.
The findings emphasize the necessity for individualized care as 14% of patients experienced 30-day mortality despite the absence of thrombotic events.

Cite This Study

Alsuhebany et al. (2025) studied this question.

synapsesocial.com/papers/68c1a13a54b1d3bfb60dc92b https://doi.org/10.3389/fcvm.2025.1573080

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark